Raymond James & Associates’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-20,000
Closed -$215K 3345
2017
Q1
$215K Sell
20,000
-40,000
-67% -$550K ﹤0.01% 2893
2016
Q4
$667K Buy
+60,000
New +$1.1M ﹤0.01% 2159

Other funds holding BHC

Raymond James & Associates's BHC Position: Q3 2024 in Review

Raymond James & Associates reduced its Bausch Health (BHC) stake by 23% in Q3 2024, selling an estimated $42.2K and leaving 21,253 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

Raymond James & Associates first reported a position in BHC in Q3 2013 and has held it in 45 quarters since. The position peaked at $5.95M in Q2 2015. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Raymond James & Associates held 21,253 shares of Bausch Health worth $173K as of Q3 2024.
  • Raymond James & Associates sold 6,399 Bausch Health shares in Q3 2024, an estimated $42.2K.
  • Bausch Health made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3683 holding.
  • Raymond James & Associates first reported a position in Bausch Health in Q3 2013 and has held it in 45 quarters since.
  • Raymond James & Associates's Bausch Health position peaked at $5.95M in Q2 2015.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.